Trial Profile
Study of effect of treatment with mepolizumab in subjects with aspirin-exacerbated respiratory disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Aspirin-induced asthma; Asthma
- Focus Pharmacodynamics
- 24 Jun 2021 New trial record
- 15 Jun 2021 Results published in the Journal of Allergy and Clinical Immunology.